Veterinary dermatology is also referred as pet skin care, it is diagnosis, treatment, and prevention of skin problems in animals. Dermatological disorders or skin disorders are the most common medical conditions that are seen in the animals. The most common sign of a dermatological problem in animals are licking, biting, repeatedly shaking the head, and excessive scratching or chewing of fur and skin. Additional symptoms of skin problems include lumps, hair loss, dandruff, a foul odor coming from the ears or skin and a change in the texture or color pet's fur or skin.Itching is commonly seen in companion animals, for example Atopic dermatitis is the common cause of itching. For example, according to research findings conducted by Ferdowsi University of Mashhad Veterinary Teaching Hospital in Iran in 2013-2014, 20% to 40% of small animals suffer from skin problems in Iran. Globally, this number may be even higher. Alternatively, variations in clinical presentations such as the extent of lesions, genetic factors, secondary infections, stage of the disease, and weather conditions could complicate the exact diagnosis of the disease. Atopy is genetically determined predisposition to become allergic to airborne pollens such as grass, weeds, trees, mold, and house dust. In domestic pets such as cats and dogs, atopic dermatitis is the most common cause of biting, chewing, rubbing or ear infections as well as other chronic infections.
The global veterinary dermatology drugs market is projected to grow at a rapid pace in the next few years. Key factors contributing to veterinary dermatology drugs market growth are rise in demand of local anesthetics, anti-inflammatory agents, emollients to treat acne, cleansers, and anti-infectives. Moreover, increase in demand for veterinary and related products such as dairy and agriculture products and rise in awareness about veterinary dermatology drugs are anticipated to drive the global veterinary dermatology drugs market. Furthermore, advancement in techniques for the development of innovative products, rise in number of mergers, collaborations, and acquisitions between companies, vendors, and academic & research institutes are expected to drive the global veterinary dermatology drugs market. However, high cost of drugs, lack of awareness about new drugs & techniques in developing countries, and stringent rules and regulations by the governing organizations are likely to hamper the growth of the global veterinary dermatology drugs market.
The global veterinary dermatology drugs market can be segmented based on type of product, animal type, and end-user. Based on type of product, the veterinary dermatology drugs market can be classified into non-steroidal anti-inflammatory drugs (NSAIDS), antibiotics, veterinary antifungal drugs, and others. Different types of antibiotics are used to treat animal dermatology conditions; however, beta lactam antibiotics such as cephalexin or potentiated amoxicillin are most commonly used. Based on animal type, the global veterinary dermatology drugs market can be bifurcated into large animals and small animals. The small animals segment is projected to account for large market share during forecast period. In terms of end-user, the veterinary dermatology drugs market can be divided into veterinary hospitals, veterinary clinics, and others.
Based on region, the global veterinary dermatology drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global market during the forecast period. This is attributed to rise in pet ownership, easy adoption of new products and techniques, better reimbursement policies, and advanced veterinary health care infrastructure. Europe and Asia Pacific are expected to be lucrative markets for veterinary dermatology drugs because of high demand for veterinary and related products in countries such as France, China, Germany, the U.K., Japan, and India. Moreover, increase in per capita income has led to high pet adoption rate in these countries.
Key players in the global veterinary dermatology drugs market are Merial, Zoetis, Inc., Ceva Sante Animale, Vetmedica, IDEXX Laboratories, Vetoquinol S.A., Virbac S.A., Bayer Animal Health, Boehringer Ingelheim, and Elanco.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.